Bill Would Stop Medicare Payments To Unlicensed Orthotics Providers
This article was originally published in The Gray Sheet
Executive Summary
Reps. Glenn ‘GT’ Thompson, R-Pa., and Mike Thompson, D-Calif., have introduced legislation banning CMS from reimbursing unaccredited or unlicensed orthotics and prosthetics providers. The bill comes after a report, commissioned by the American Orthotic and Prosthetic Association, showed that CMS’ efforts to eliminate payments to unlicensed providers have been ineffective.
You may also be interested in...
Reimbursement Briefs: OIG, CMS Address DME; Cigna Genetic Testing Policy Takes Effect
OIG released reports pressing for reduced Medicaid payments on DME. Meanwhile, CMS delayed again the face-to-face requirement for DME reimbursement and updated its oxygen supplier policy. A new policy at insurer Cigna took effect to require genetic counseling prior to genetic testing for certain conditions.
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.